T. J. Hamblin

Q: What Schools Are Affiliated With T. J. Hamblin

T. J. Hamblin is affiliated with the following schools: University of Bristol, Bournemouth University, King's College London, University of Southampton

T. J. Hamblin's AcademicInfluence.com Rankings

T. J. Hamblin

Biology

#6645

World Rank

#9408

Historical Rank

Immunology

#366

World Rank

#380

Historical Rank

biology Degrees

Download Badge

Biology

Why Is T. J. Hamblin Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Terence John Hamblin was a British academic and scientist who was professor of Immunohaematology at the University of Southampton from 1987 until his death. Life and career Born in Worcester, England, Hamblin's early years were spent in Aldershot in Hampshire where he and his family lived on Cambridge Road; he was educated at Farnborough Grammar School and the University of Bristol.

(See a Problem?)

T. J. Hamblin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International scoring system for evaluating prognosis in myelodysplastic syndromes. (1997) (4221)
Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. (1999) (2637)
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. (2003) (882)
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. (2002) (677)
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia (2004) (608)
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial (2007) (592)
Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. (2002) (582)
Myelodysplastic syndromes: a scoring system with prognostic significance (1985) (514)
B-cell chronic lymphocytic leukemia: a bird of a different feather. (1999) (445)
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia (1999) (426)
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. (2003) (340)
DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma (1998) (319)
Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients (1996) (298)
Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials (1999) (295)
Adaptor protein 3–dependent microtubule-mediated movement of lytic granules to the immunological synapse (2003) (247)
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. (2008) (243)
Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. (2002) (240)
PLASMAPHERESIS IN THE MANAGEMENT OF ACUTE SYSTEMIC LUPUS ERYTHEMATOSUS? (1976) (228)
Autoimmunity in chronic lymphocytic leukaemia. (1986) (226)
Differentiation of iron deficiency from thalassaemia trait. (1973) (197)
Immunoglobulin V genes and CD38 expression in CLL. (2000) (196)
Autoimmune complications of chronic lymphocytic leukemia. (2006) (189)
Immunological abnormalities in myelodysplastic syndromes I. SERUM IMMUNOGLOBULINS AND AUTOANTIBODIES (1986) (185)
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial. (2012) (184)
The immunodeficiency of chronic lymphocytic leukaemia. (2008) (181)
Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival (1988) (161)
Chronic lymphocytic leukemia. (2010) (160)
Fludarabine‐related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia (1995) (147)
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. (2008) (139)
The occurrence and significance of V gene mutations in B cell-derived human malignancy. (2001) (136)
Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. (2005) (132)
Insight into the origin and clonal history of B‐cell tumors as revealed by analysis of immunoglobulin variable region genes (1998) (122)
Immunological abnormalities in myelodysplastic syndromes II. COEXISTENT LYMPHOID OR PLASMA CELL NEOPLASMS: A REPORT OF 20 CASES UNRELATED TO CHEMOTHERAPY (1986) (109)
Differentiation of iron deficiency from thalassemia trait by routine blood-count. (1973) (103)
Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long‐term blood transfusions (2007) (102)
Identification of normal B‐cell counterparts of neoplastic cells which secrete cold agglutinins of anti‐I and anti‐i specificity (1989) (100)
Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. (1986) (97)
Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12 (1997) (97)
Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. (2002) (94)
Establishing the incidence of myelodysplastic syndrome. (1994) (92)
Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations. (1983) (84)
Correlation of chromosome abnormalities with laboratory features and clinical course in B‐cell chronic lymphocytic leukaemia (1990) (76)
Chronic lymphocytic leukaemia: one disease or two? (2002) (75)
CEREBRAL BLOOD-FLOW IN POLYCYTHÆMIA (1977) (71)
Prognostic factors in chronic lymphocytic leukemia (2006) (69)
Leukaemia and Lymphoma—an atlas of distribution within areas of England and Wales, 1984–1988 (1990) (69)
Chronic lymphocytic leukaemia: the nature of the leukaemic cell. (1997) (68)
Prognostic markers in chronic lymphocytic leukaemia. (2007) (67)
The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. (2002) (64)
Establishing the incidence of myelodysplastic syndrome (1994) (63)
The myelodysplastic syndrome—a practical guide (1987) (58)
Circulating stem cell autografts. (1986) (57)
CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3. (1991) (54)
Immunologic abnormalities in myelodysplastic syndromes. (1992) (54)
Disappointments in treating acute leukemia in the elderly. (1995) (53)
Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukemia. (1983) (53)
Immunological reason for chronic ill health after infectious mononucleosis. (1983) (52)
Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene. A possible link between infection and lupus. (1995) (50)
PERIPHERAL BLOOD STEM CELL AUTOGRAFTING (1986) (49)
Chronic Lymphatic Leukaemia: Correlation of Immunofluorescent Characteristics and Clinical Features (1977) (48)
Red cell aplasia in myelodysplastic syndrome. (1991) (47)
Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia – long‐term follow up of patients with different percentages of mutations (2008) (46)
Appelbaum FR, Rowe JM, Radich J, Dick JE. Acute Myeloid Leukemia. Hematology Am Soc Hematol Educ Program. 2001:62-86. PMID: 11722979 (2008) (44)
The treatment of acute myeloid leukaemia preceded by the myelodysplastic syndrome. (1992) (42)
Antibody therapy for treatment of multiple myeloma. (1999) (40)
Coexistent myelodysplasia and plasma cell neoplasia (1983) (40)
Anti‐idiotype vaccines (2003) (39)
Disturbances in peripheral blood B cell subpopulations in autoimmune patients (2002) (38)
Common Patterns of B Cell Perturbation and Expanded V4-34 Immunoglobulin Gene Usage in Autoimmunity and Infection (2004) (38)
Serous effusions in monocytic leukaemias (1984) (38)
TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKAEMIA WITH LOW DOSE ETOPOSIDE (1989) (37)
Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin (1995) (37)
Response of B-cell lymphoma to a combination of bispecific antibodies and saporin. (1996) (37)
Management of multiple myeloma today. (1999) (36)
Clinical features of MDS. (1992) (36)
Assessment of fl udarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial (2007) (36)
Initial experience in treating human lymphoma with a combination of bispecific antibody and saporin. (1992) (34)
Unmutated immunoglobulin VH genes are associated with a more aggressive form of chronic lymphocyte leukemia (1999) (32)
Severe deafness in systemic lupus erythematosus: its immediate relief by plasma exchange. (1982) (32)
Long‐term survival associated with metastatic small cell carcinoma of the esophagus treated by chemotherapy, autologous bone marrow transplantation, and adjuvant radiation therapy (1994) (31)
Monocytic skin infiltration in chronic myelomonocytic leukaemia. (1986) (30)
Reciprocal translocation between chromosomes 8 and 9 in atypical chronic myeloid leukaemia. (1985) (29)
Predicting Progression--ZAP-70 in CLL. (2004) (29)
A Pilot Study of Idiotypic Vaccination for Follicular B-cell Lymphoma Using a Genetic Approach. University of Bristol, Bristol, United Kingdom (1997) (29)
Toxic confusional state and choreiform movements after treatment with anabolic steroids. (1981) (28)
The chromosomes in human cancer and leukemia (1992) (28)
Fludarabine and hemolytic anemia in chronic lymphocytic leukemia. (1998) (27)
Successful Treatment of Post‐Transfusion Purpura with High Dose Immunoglobulins after Lack of Response to Plasma Exchange (1985) (27)
Coincident chronic lymphocytic leukemia and osteosclerotic multiple myeloma. (1981) (27)
Have we been wrong about ionizing radiation and chronic lymphocytic leukemia? (2008) (26)
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group. (2000) (25)
Pattern of usage of the VH4-21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching. (1995) (25)
The effect of plasma exchange on the in vitro monocyte function of patients with immune complex diseases. (1981) (25)
Distinctive cytoplasmic inclusions in chronic lymphocytic leukaemia. (1975) (24)
Non-hemic autoimmunity in CLL. (2009) (23)
Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gamma. (1988) (23)
Differentiation induction in myelodysplasia and acute myeloid leukaemia: use of synergistic drug combinations. (1987) (22)
Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score. (1989) (22)
VERY-LOW-DOSE CYTARABINE FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKAEMIA IN THE ELDERLY (1986) (22)
A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma. (1989) (22)
Use of circulating stem cells to accelerate myeloid recovery after autologous bone marrow transplantation. (1987) (21)
Long survival in B‐CLL correlates with surface IgMK phenotype (1987) (21)
Prognostic factors in stage AO B‐cell chronic lymphocytic leukaemia (1990) (21)
TRUE OUTLOOK IN ACUTE MYELOBLASTIC LEUKAEMIA (1986) (19)
The immune response to phichi174 in man. IV. Primary and secondary antibody production in patients with chronic lymphatic leukaemia. (1975) (19)
Chromosomal abnormalities in B-CLL. (1988) (18)
Treatment of acute myeloid leukemia in the elderly: A clinical dilemma (1989) (18)
CD38: what is it there for? (2003) (18)
Natural products and the treatment of leukemia. (2006) (17)
Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemia (2005) (17)
SIGNIFICANCE OF ANTIMITOCHONDRIAL ANTIBODIES (1981) (17)
Pyogenic abscesses in the myelodysplastic syndrome. (1989) (16)
Relapsing polychondritis, smouldering non-secretory myeloma and early myelodysplastic syndrome in the same patient: three difficult diagnoses produce a life threatening illness. (2000) (16)
Colony-Stimulating Factors in the Treatment of Older Patients with Acute Myelogenous Leukaemia (1999) (15)
Plasmapheresis in Crohn's disease. (1979) (15)
7 Chronic lymphocytic leukaemia (1987) (15)
IN PATIENTS WITH LYMPHOID TUMOURS RECOVERING FROM THE AUTOIMMUNE COMPLICATIONS OF FLUDARABINE, RELAPSE MAY BE TRIGGERED BY CONVENTIONAL CHEMOTHERAPY (1998) (14)
Is "leukemia" an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia? (2007) (14)
Peripheral blood stem cell autografting (1987) (14)
Plasmapheresis and a placebo procedure in autoerythrocyte sensitisation. (1981) (14)
Application of the international scoring system for myelodysplasia to M.D. Anderson patients [3] (multiple letters) (1997) (14)
Is chronic lymphocytic leukemia a response to infectious agents? (2006) (14)
Intensive chemotherapy in myelodysplastic syndromes. (1992) (14)
Richter's syndrome--the downside of fludarabine? (2005) (14)
Early transformation to acute myeloblastic leukaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia. (1997) (14)
From dendritic cells to tumour vaccines (1996) (14)
Use of a retinoblastoma gene probe to investigate clonality in Richter's syndrome. (1993) (13)
Plasmapheresis in Rh Hemolytic Disease: The Danger of Amniocentesis (1983) (13)
The TCL1 mouse as a model for chronic lymphocytic leukemia. (2010) (13)
Management of cold agglutination syndrome. (2000) (13)
Basic isoferritin and hypercalcaemia in renal cell carcinoma (1982) (13)
A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer. (1993) (13)
Minimal diagnostic criteria for the myelodysplastic syndrome in clinical practice. (1992) (12)
Just exactly how common is CLL? (2009) (12)
RELAPSE AFTER AUTOGRAFTING WITH PERIPHERAL BLOOD STEM CELLS (1988) (12)
Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia. (2011) (12)
What about the bleeding time? (1985) (11)
AN APHERESIS REGISTER (1982) (11)
t(8:21) Myelodysplasia. (1996) (11)
Dual Recognition of Lipid A and DNA by Human Antibodies Encoded by the VH4‐21 Gene A Possible Link between Infection and Lupus a (1995) (11)
Interleukin-2 and lymphokine activated killer cells (1991) (11)
Somatic mutation of bcl-6 genes can occur in the absence of VH mutations in chronic lymphocytic leukemia (2000) (11)
A patient with myeloma who still has pure red cell aplasia despite the most intensive immune modulation. (1997) (10)
Achieving Optimal Outcomes in Chronic Lymphocytic Leukaemia (2012) (10)
Blood transfusions and cancer: anomalies explained? (1986) (10)
CYTARABINE IN PRE-LEUKAEMIA (1984) (10)
Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes (1987) (10)
Acute transformation of a myeloproliferative state in sideroblastic anaemia with abnormal karyotype. (1982) (9)
Chronic lymphocytic leukaemia: clinical translations of biological features. (2005) (9)
Activation of Ha-ras in human chronic granulocytic and chronic myelomonocytic leukaemia. (1988) (9)
COEXISTENT LYMPHOID OR PLASMA CELL NEOPLASMS (1987) (9)
Melphalan-induced pulmonary fibrosis in osteosclerotic myeloma. (1983) (9)
DNA vaccines against haematological malignancies. (1999) (9)
Immunology Aspects of the Myelodysplastic Syndromes (2002) (9)
The Aplasia-Leukaemia Syndrome (1983) (9)
Primary myelodysplastic syndrome with complex chromosomal rearrangements in a patient with Klinefelter's syndrome. (1986) (9)
What Are the Established Clinical Indications for Therapeutic Plasma Exchange and How Important Is the Choice of Replacement Fluid for Efficacy of Therapeutic Plasma Exchange in These Situations? (1982) (8)
Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency. (2007) (8)
In Chronic Lymphocytic Leukemia Females Survive for Longer Than Males Even in Patients with Unmutated Immunoglobulin Genes. (2004) (7)
1st International Conference on Reversal of Multidrug Resistance in Cancer. St. Gallen, Switzerland, 1-3 September 1994. (1995) (7)
Exercise-induced urticaria and angio-oedema with relief from cromoglycate insufflation. (1983) (7)
CO-TRIMOXAZOLE AND THE BLOOD (1973) (7)
Where now for therapeutic apheresis? (1984) (6)
Polyarteritis presenting with thrombocytosis and palliated by plasma exchange. (1978) (6)
The kidney in myeloma. (1986) (6)
Pseudo-myelodysplastic syndrome with t(8;21) (1994) (6)
Rosette tests in autoimmune haemolytic anaemias. (1970) (6)
Trisomy 12 in CLL revisited. (1997) (6)
Must plagiarism thrive? (1980) (6)
Hairy cell leukaemia and Legionnaires' disease. (1985) (6)
Is chronic lymphocytic leukemia one disease? (2002) (6)
ZAP-70 levels do change in CLL but not very often (2007) (6)
The aplasia-leukaemia syndrome. Aplastic anaemia followed by dyserythropoiesis, myeloproliferative syndrome and acute myeloid leukaemia. (1983) (6)
CD3+ CD8+ T cell lymphocytosis masking B cell leukaemia. (1988) (5)
ACUTE VINCRISTINE NEUROTOXICITY (1985) (5)
The effect of an intravenous histidine load on the plasma level of other amino acids. (1972) (5)
Chronic lymphocytic leukaemia. (1987) (5)
Pattern of Usage of the VH4–21 Gene by B Lymphocytes in a Patient with EBV Infection Indicates Ongoing Mutation and Class Switching a (1995) (5)
Long-Term plasma-exchange (1983) (5)
HEREDITARY ANGIONEUROTIC ŒDEMA (1973) (5)
Historical aspects of chronic lymphocytic leukaemia (2000) (5)
Immunological reconstitution after bone marrow transplantation with Campath-1 treated bone marrow. (1988) (5)
Myelodysplastic syndromes. Clinical and biological advances (2006) (5)
The Secret Life of Dr Chandra (2006) (4)
The management of anemia in the myelodysplastic syndrome. (2005) (4)
Mechanisms in removal of tumor by antibody (2007) (4)
How Many Somatic Mutations Should We allow the Subset of Chronic Lymphocytic Leukemia with Unmutated IgVH Genes (2004) (4)
Oldest case of sarcoidosis in the world. (1981) (4)
MEGALOBLASTIC ANÆMIA WITH NORMAL MEAN CELL VOLUME (1979) (4)
Cytokines to reduce platelet transfusions: non-TPO cytokines. (1997) (4)
Long survival in B-CLL correlates with surface IgM kappa phenotype. (1987) (4)
PLASMA EXCHANGE IN SLE (1980) (4)
Interaction between warfarin and phenformin. (1971) (4)
Evolution of a terminal deoxynucleotidyl transferase-positive lymphoma from a chronic T cell lymphocytosis. (2009) (4)
Angio-immunoblastic lymphadenopathy with hypogammaglobulinaemia complicated by miliary tuberculosis. (1985) (3)
NEUTROPENIA AND IRON THERAPY (1976) (3)
Conventional treatments vs. gene therapy (2006) (3)
Fake. (1981) (3)
DNA vaccination against cancer antigens. (2000) (3)
Mononucleosis and the miniskirt: an incompatible combination. (1972) (3)
Angiodysplasia of the Colon in Patients with Hemostatic Defects: Risk of Secondary Hemorrhage After Electrocoagulation Treatment (1984) (3)
Milestones in leukaemia research and therapy: Freireich E. J. & Lemak N. A. (Johns Hopkins University Press, Baltimore, U.S.A.), 260 pages (1992) (3)
Immunological Abnormalities in the Myelodysplastic Syndrome (1992) (3)
Polycythemia rubra vera and Hairy Cell Leukaemia / Reply (1985) (2)
Waiting in the NHS (2002) (2)
Polyfunctionality of Hemopoietic Regulators: The Metcalf Forum: Edited by Martin J. Murphy Jr. Alpha Med Press, Dayton, Ohio, U.S.A. (1995) (2)
Ex vivo activation and retransfusion of white blood cells. The immunotherapy of cancer. (1990) (2)
LEUCOCYTE ALLOANTIGENS IN THE KIDNEY II. A QUANTITATIVE APPROACH (1972) (2)
UK CLL Forum, London, 25th October 2001. (2002) (2)
Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia: no country for old men? (2009) (2)
Immunological abnormalities in myelodysplastic syndromes. (1996) (2)
Immune guided missiles. (1982) (2)
Long-term plasma-exchange. (A feasible treatment in systemic lupus erythematosus and other diseases). (1983) (2)
NAFAZATROM IN THROMBOCYTOPENIC PURPURA (1986) (2)
Heterogeneity in neoplastic cell populations in chronic lymphocytic leukaemia defined by immunoglobulin expression and secretion in vitro. (1988) (2)
Polycythemia rubra vera and hairy cell leukemia. (1985) (2)
Syndromes International Scoring System for Evaluating Prognosis in Myelodysplastic (2010) (2)
Clinical parameters for evaluating biological response modifier therapy. (1989) (2)
A shocking American report with lessons for us all (1987) (2)
Relapse of lymphoma in the heart after a 10-year remission. (1984) (2)
Historical aspects of chronic lymphocytic leukaemia. (2000) (2)
PLASMA IRON AND IRON-BINDING CAPACITY (1975) (2)
Immunotherapy of Disease (1989) (2)
The Heterogeneous Origin of the B-CLL Cell (2004) (2)
DNA Vaccines against B-cell tumors (2000) (2)
Ligandless receptors find a role. (2008) (2)
Myelodysplastic Syndromes and Secondary Acute Myelogenous Leukemia (2002) (2)
Interleukin-2 for anti-cancer therapy. (1991) (1)
Interleukin 2: Author's Reply (1990) (1)
Antibody treatment of lymphoma: experience and prospects (1996) (1)
Differential Expression of CD180 and sIgM by B Chronic Lymphocytic Leukaemia Cells (B-CLL) Using Mutated and Unmutated IgVh Genes. (2004) (1)
E3) Has survival improved in the past ten years (1991) (1)
Letter: Treatment of myeloma kidney. (1976) (1)
The Body in Question (1979) (1)
Effects of Anti-inflation Policy (1975) (1)
Blood counts and economics. (1983) (1)
Leukaemia diagnosis. A guide to the FAB classification (1991) (1)
The Problems of Anticoagulant Control—1. Drug Interactions (1970) (1)
Interleukin 2 (1990) (1)
Proceedings: The therapeutic use of plasmapheresis in an immune complex disease. (1976) (1)
E. Donnall Thomas, M.D. Nobel laureate 1990. (1991) (1)
Clinician's overview of platelet support. (1997) (1)
THE DOSE OF ANTI-D IMMUNOGLOBULIN (1977) (1)
Apheresis in rheumatoid arthritis. (1984) (1)
Plasma exchange to control sweats and pruritus in malignant disease. (1981) (1)
Developments in Biological Standardisation, Monoclonal Antibodies for Therapy, Prevention and In Vivo Diagnosis of Human Disease (1991) (1)
The Combination of Fludarabine and Cyclophosphamide Has a Beneficial Effect on the Incidence of Hemolytic Anemia in Chronic Lymphocytic Leukemia. Results from the UK LRF CLL4 Trial. (2007) (1)
Indomethacin, ranitidine, and interleukin-2 in melanoma (1992) (1)
Letter: Co-trimoxazole and the blood. (1973) (1)
Contributions to oncology, vol. 10: Plasmapheresis in immunology and oncology edited by J.-H. Beyer, H. Borberg Ch. Fuchs and G. A. Nagel, S. Karger, 1982. DM 70.00/$42. 00 (viii + 266 pages) ISBN 3 805 534671. (1983) (1)
PLATELET COLD AGGLUTININS (1975) (1)
Withholding treatment in infancy (1981) (1)
Apheresis therapy: spin-drying the blood. (1982) (1)
The Myelodysplastic Syndromes (MDS) Foundation: a retrospective analysis of a nonprofit foundation. (2011) (1)
Medical bioresearch and scientific integrity. (1994) (1)
Lymphokine-Activated Killer Cells From Normal and Lymphoma Subjects Are Cytotoxic for Cells Coated With Antibody Derivatives Displaying Human Fc (2005) (1)
Colony-stimulating factors: Molecular and cellular biology (immunology series/49), (Dexter T.M., Garland J.M. & Testa N.G., eds), (Marcel Dekker, New York) 504 pages, $135 (U.S.A. and Canada), $162 elsewhere, hard back (1991) (0)
What's wrong with the funding of cancer research? (1982) (0)
Endothelins. (1990) (0)
and cyclophosphamide on the incidence of hemolytic anemia fludarabine lymphocytic leukemia - a beneficial effect of the combination of The prognostic significance of a positive direct antiglobulin test in chronic (2013) (0)
Welcome to a new editor (1993) (0)
Reconstitution of interleukin-2 with albumin for infusion (1990) (0)
Oncogenes in Cancer diagnosis (1991) (0)
Chronic Lymphocytic Leukaemia—New Drugs and Management (1995) (0)
Letter: Plasma iron and iron-binding capacity. (1975) (0)
Under-reporting of clinical trials is a well known 'occupational hazard'. (1998) (0)
Cancer research. (1972) (0)
Cytokines: a barely believable story (1991) (0)
So, What Is a Clinical Oncologist? (1992) (0)
Modifications of Monoclonal Antibody for Immunotherapy (1989) (0)
Discussion of Poster Session III (1992) (0)
Plasmid vaccination for B-cell lymphoma (1995) (0)
Monoclonal anti light chain idiotype as a tumor specific probe for human b cell lymphoma (1987) (0)
Myth or fact? (1982) (0)
CLOVEN (NOT CLEAVED) CELLS (1976) (0)
Stem cell grafting from hematological rescue to somatic gene therapy (1996) (0)
TheAssociation ofClinical Pathologists: 95thgeneral meeting (1976) (0)
Christmas Books: Lifting the skirts of science (1983) (0)
The use of antibody in the malignant blood diseases (1985) (0)
Medicine in Contemporary Society: King's College Studies 1986-7 (1988) (0)
Euthanasia. (1992) (0)
(G1) The past, the present and the future (1991) (0)
Pathophysiology of blood. Edited by A. A. Mackinney Jr. John Wiley, New York, Chichester. 1984. No. of pages: xvi + 363. Price: £22.70. ISBN: 0 471 08245 7 (1985) (0)
A comparison of oral and intravenous fludarabine in the LRF CLL4 trial (on behalf of the UKNCRI CLL trials group) (2006) (0)
John Eliot Trapnell (2011) (0)
Book Review Chronic Lymphocytic Leukemia Edited by Susan O'Brien and John G. Gribben. 301 pp., illustrated. New York, Informa Healthcare, 2008. $199.95. 978-1-4200-6895-5 (2009) (0)
Malignant LymphomasDecision Making and Problem Solving (2005) (0)
Inconsistency over payment (2008) (0)
Problems of Anticoagulant Control—II, Which Test? (1971) (0)
IS YOUR IRON AND IRON-BINDING CAPACITY REALLY NECESSARY? (1975) (0)
New technologies in transfusion: Monoclonal antibodies (1989) (0)
FCRL2 expression predicts IGHVmutation status and clinical progression in chronic lymphocytic leukemia. Commentary (2008) (0)
Hairy Cell Leukemia (Advances in Blood Disorders Series; vol. 5), Martin S. Taliman and Aaron Polliak (Eds.), Harwood Academic Publishers, Amsterdam, ISBN 90-5823-009-0 (2001) (0)
Glycosylation of V region genes in follicular lymphoma as a result of the somatic hypermutation mechanism (2002) (0)
A shocking American report with lessons for all. (1987) (0)
Leukemia research thirteen years on (1989) (0)
46 Recent developments in the prognostic classification for MDS: Results of The International Risk Analysis Workshop (1997) (0)
Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytes. (1987) (0)
(B7) Establishing the incidence of MDS-population surveys (1991) (0)
Recent advances in the management of myelodysplastic syndromes. (1993) (0)
Phase II Study of Continuous Subcutaneous Interferon-Alfa Combined with Cisplatin in Advanced Malignant Melanoma (1992) (0)
neoplastic B lymphocytes Monoclonal anti-light chain idiotype as a tumor-specific probe for human (2011) (0)
Comparison of scoring systems for prognosis in MDS (1994) (0)
Advances in chronic lymphocytic leukemia. Proceedings from the 5th International Workshop an Chronic Lymphocytic Leukemia: Polliack A. & Montserrat E. (eds), (Harwood Academic Publishers, Switzerland) (1992) (0)
BLOOD DONORS, PAID OR UNPAID? (1980) (0)
Leukaemia or megaloblastic anaemia? (1970) (0)
Autoimmune and Hypersplenic Cytopenias (2004) (0)
The Use of Human Beings in Research (1989) (0)
Personal View (1974) (0)
Letter: Neutropenia and iron therapy. (1976) (0)
Book Review Multiple Myeloma Edited by Gösta Gahrton and Brian G.M. Durie. 219 pp. London, Arnold, 1996. (Copublished with Oxford University Press, New York.) $89.50. 0-340-57603-0 (1997) (0)
Book Review The Lymphomas Second edition. Edited by George P. Canellos, T. Andrew Lister, and Bryan Young. 582 pp., illustrated. Philadelphia, Saunders, 2006. $199. 0-7216-0081-6 (2006) (0)
human B cell tumors Antibodies to shared idiotypes as agents for analysis and therapy for (2011) (0)
Advertisements for doctors with particular religious beliefs (1983) (0)
Book Review / Announcements (1983) (0)
New approaches to the treatment of leukemia: Marmont A. M., McCulloch E. A., Rees J. K. H., Reizenstein P. & Wiernick P. H. (eds), (Springer, Berlin), $98.00 (1992) (0)
The future in apheresis: the cell revisited. (1990) (0)
SELECT COMMITTEE ON ABORTION (1976) (0)
derivative of monoclonal anti-idiotype antibody Initial experience in treating human lymphoma with a chimeric univalent (2011) (0)
70 Immunology of MDS, towards a DNA vaccine (1997) (0)
A shocking American report with lessons for us all. (1987) (0)
Transfusion therapy: Clinical principles and practice, Paul D. Mintz, editor. 2nd ed. AABB Press, Bethesda, Maryland (2005), p. 716. ISBN: 1-56395-185-1. (2006) (0)
Preferential expression of CD180 by B cell chronic lymphocytic leukaemia (B-CLL) cells using IgVh mutated than those using IgVh unmutated genes (2003) (0)
Uniform publishing criteria for clinical trials (1995) (0)
Circulating stem cell autografts in the treatment of hematologic malignancies (1988) (0)
Pyoderma gangrenosum (1998) (0)
tumor microenvironment CD38 expression in chronic lymphocytic leukemia is regulated by the (2013) (0)
Bone Marrow Disorders. The Biological Basis of Clinical Problems. Myrtle Gordon and John Barrett. Blackwell Scientific Publications, Oxford, 1985. ISBN 0 632 01163 7. £35.00 (1986) (0)
Haemolytic Anaemias, VOL. 1. The Hereditary Haemolytic Anaemias. Part 1. 3rd edn. Sir John Dacie. Churchill Livingstone, Edinburgh, 1985. ISBN 0443 015430 (1986) (0)
Cytokines to replace platelet transfusions (1997) (0)
Open forum--Are myelodysplastic syndromes cancer? Response to Dr. Steensma. (2007) (0)
Interleukin-2 for anti-cancer therapy : Cancer (1991) (0)
Induction and expansion of LAK cells for cancer immunotherapy. (1990) (0)
More fun in Holy Writ (1989) (0)
CLL: to mend it or be rid of it (2004) (0)
The motives of fakers (1980) (0)
Plasma Exchange in SLE (1980) (0)
Appointment of assistant editors (1996) (0)
Reading for Pleasure: More worlds per pound (1980) (0)
Professor Peter Reizenstein (1993) (0)
Letter: Platelet cold agglutinins. (1975) (0)
The blood and bone marrow vol. 2 systemic pathology. 3rd edn. S. N. Wickramsinghe with contributions by Barbara Bain. Churchill Livingstone, Edinburgh, 1986. No. of pages: x + 356. Price: £50.00. ISBN: 0 433 030995 (1987) (0)
Relapse oflymphoma intheheart after a10-year remission (1984) (0)
CONFIDENTIALITY (1984) (0)
Cerebral blood-flow in polycythaemia. (1977) (0)
CD‐ROM Atlas of Hematology (1999) (0)
Book Review: Therapeutic Apheresis and Plasma Perfusion (1983) (0)
Bone marrow biopsies updated. Edited by B. Frisch and R. Bartl. S. Karger, Basel, 1984. No. of pages: viii + 132. Price: U.S. $58.75. ISBN: 3 8055 3863 4 (1985) (0)
Adult Acute Leukaemia—A Suitable Case for Treatment? (1973) (0)
LEUCAPHERESIS (1990) (0)
Therapeutic Apheresis and Plasma Perfusion: Progress in Clinical and Biological Research, vol 106 (1983) (0)
Depletion of Lymphocytes from Bone Marrow — Indications, Expectations and Clinical Experience (1988) (0)
gene expression profile unmutated immunoglobulin genes, inferior clinical outcome, and distinct ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with (2013) (0)
Autumn Books: The paranormal defended (1986) (0)

This paper list is powered by the following services:

Other Resources About T. J. Hamblin

en.wikipedia.org

What Schools Are Affiliated With T. J. Hamblin?

T. J. Hamblin is affiliated with the following schools: